GPCR - Structure Therapeutics Inc.
63.13
0.095 0.150%
Share volume: 624,070
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$63.04
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-13-2024 | 02-27-2025 | 05-08-2025 | 11-06-2025 | 02-26-2026 | |
| Assets | ||||||||
| Total Assets | 457.225 M | 947.029 M | 933.217 M | 903.330 M | 866.549 M | 832.159 M | 1.584 B | |
| Current Assets | 449.360 M | 937.621 M | 923.651 M | 891.211 M | 849.622 M | 814.022 M | 1.570 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 338.617 M | 545.492 M | 743.156 M | 714.008 M | 684.759 M | 696.131 M | 646.574 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 97.832 M | 381.627 M | 172.130 M | 169.510 M | 152.123 M | 102.912 M | 799.623 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 3.120 M | 3.315 M | 3.735 M | 3.478 M | 3.518 M | 4.675 M | 6.653 M | |
| Other Assets | 4.745 M | 6.093 M | 5.831 M | 8.641 M | 13.409 M | 13.462 M | 6.962 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 457.225 M | 947.029 M | 933.217 M | 903.330 M | 866.549 M | 832.159 M | 1.584 B | |
| Total liabilities | 27.407 M | 25.997 M | 36.416 M | 38.487 M | 41.911 M | 62.140 M | 67.541 M | |
| Total current liabilities | 23.586 M | 22.659 M | 33.434 M | 36.021 M | 36.487 M | 57.527 M | 63.285 M | |
| Accounts Payable | 6.538 M | 2.209 M | 8.447 M | 8.024 M | 8.710 M | 17.796 M | 13.864 M | |
| Other liabilities | 3.821 M | 3.338 M | 2.982 M | 2.466 M | 5.424 M | 4.613 M | 4.256 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 3.821 M | 3.338 M | 2.982 M | 2.466 M | 5.424 M | 4.613 M | 4.256 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 429.818 M | 921.032 M | 896.801 M | 864.843 M | 824.638 M | 770.019 M | 1.516 B | |
| Common stock | 662.516 M | 1.180 B | 1.187 B | 1.193 B | 1.200 B | 1.272 B | 1.986 B | |
| Retained earnings | -232.608 M | -258.642 M | -292.619 M | -329.098 M | -375.931 M | -503.304 M | -470.300 M |